Actavis, Inc. (ACT) [Rocket]

News + Filings

All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Appointed CFO
Quarterly results
Credit agrmnt [a]
Acq. announced
Director departure
CC transcript

Actavis, Inc. (ACT)

Create: Alert

All | News | Filings

Date Filed	Type	Description
08/09/2013	3	DArecca James (Chief Accounting Officer) has filed a Form 3 on Actavis, Inc.
11/05/2012	3	Fridriksdottir Hafrun (Sr VP,Global Generics R&D) has filed a Form 3 on WATSON PHARMACEUTICALS INC
05/21/2012	3	Eagan Patrick (SVP, Human Resources-Global) has filed a Form 3 on WATSON PHARMACEUTICALS INC
09/02/2010	3	Olafsson Sigurdur O (EXEC VP, GLOBAL GENERICS) has filed a Form 3 on WATSON PHARMACEUTICALS INC
07/12/2010	3	Form 3 - Initial statement of beneficial ownership of securities
12/10/2009	3	Tabatznik Anthony Selwyn (Director) has filed a Form 3 on WATSON PHARMACEUTICALS INC
12/10/2009	3	Power Anna (Sr VP,Global Generics) has filed a Form 3 on WATSON PHARMACEUTICALS INC
11/17/2009	3	Stewart Robert A (Sr VP,Global Operations) has filed a Form 3 on WATSON PHARMACEUTICALS INC
09/22/2009	3	Wilkinson George Fred (Exec.VP-Global Brands) has filed a Form 3 on WATSON PHARMACEUTICALS INC
09/22/2009	3	Mayr Charles M (Sr VP,Corp.Com & Inv.Relations) has filed a Form 3 on WATSON PHARMACEUTICALS INC
06/30/2009	3	BODINE CHRIS W (Director) has filed a Form 3 on WATSON PHARMACEUTICALS INC
05/18/2009	3	Eisenhaur Patty (VP, Investor Relations) has filed a Form 3 on WATSON PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy